Abstract

Purpose
To investigate the outcomes of digital nerve repairs using processed nerve allograft for defects measuring 30 millimeters or less.
Methods
Seventeen patients with 21 digital nerve lacerations in the hand underwent reconstruction with processed nerve allograft. Outcome data for 14 patients with 18 digital nerve lacerations were available for analysis. Postoperative outcome data were recorded at a minimum of 12 months and an average of 15 months. The average nerve gap measured 11 mm (range, 5 -30 mm). Outcome measures included postoperative sensory examination as assessed by Semmes-Weinstein monofilaments and static-and moving-2 point discrimination.
Pain was graded using a visual analog scale throughout the recovery period. In addition, patients completed the Quick Disabilities of the Arm, Shoulder, and Hand survey pre-and postoperatively.
Results
Introduction
Restoration of peripheral nerve function continues to challenge surgeons despite advances in manufactured and traditional graft options and refined surgical techniques. (1, 2, 3) Segmental nerve loss often accompanies trauma to the hand making a tension-free, end-to-end repair impossible. In many cases, traumatic nerve injury requires debridement of the nerve ends, which further compromises tension-free repair. (4) In cases in which a secure, tension-free repair is not possible, the most common recommendation has been to graft the defect with a segment of autologous nerve. Autografts provide a reliable structure and environment through which axons can regenerate across a deficit. However, disadvantages include prolonged operative times, higher facility costs, and donor site morbidity which may include pain, scarring, neuroma formation, and sensory loss. (5, 6, 7, 8) Autograft alternatives include allografts and artificial nerve conduits, which eliminate donor site morbidity. Several clinical studies have documented the effectiveness of nerve conduits for short gaps (9); however, the clinical value of nerve conduits to bridge larger gaps remains unclear. (3, 9) Recent advances in allograft tissue processing have eliminated the need for immunosuppression, and allografts are becoming an attractive alternative to autografts and conduits. (10, 11, 12) Several authors have reported success with processed nerve allografts. (1, 2, 13, 14) One such allograft is the Avance® processed nerve graft (AxoGen, Inc., Alachua, FL). It consists of human nerve that has been decellularized, gamma irradiated, and subjected to enzymatic degradation of chondroitin sulfate proteoglycans with chondroitinase. As a result, the allograft is rendered nonimmunogenic while its 3-dimensional structure is maintained. (14, 15) Animal studies have shown this material to mimic autografts in macrostructure, 3-dimensional microstructural scaffolding, and protein composition. Theoretically, these qualities render 6 allograft an effective material to span peripheral nerve defects. (1, 4, 16) A recent review of the literature, however, disclosed few clinical studies evaluating the efficacy of processed allografts to reconstruct digital nerve defects in the hand. (14, 17) In a retrospective review, Karabekmez et al (14) reported on the efficacy of processed allografts for restoring adequate sensation in nerve defects ranging from 5 to 30 mm. Cho et al (17) reported on a subset of digital nerve defects up to 40 mm from an ongoing nerve registry.
The goal of this prospective study was to evaluate the clinical outcomes of digital nerve gaps in the hand measuring 30 mm or less reconstructed with processed nerve allograft.
Methods
After receiving institutional review board approval, a prospective study was conducted on patients older than 18 years of age with digital nerve lacerations not amenable to primary repair. Patients completed the Quick DASH (Disabilities of the Arm, Shoulder, and Hand) (19) survey pre-and postoperatively to quantify their pain perception and functional impairment.
Quick DASH scores range from 0 indicating no disability to 100 describing the most severe disability. Pain was recorded on a 10-point visual analog scale, where a score of 0 denoted no pain, and a score of 10 signified extreme pain. Secondary outcome measures included patient demographics, comorbidities, hand dominance, and location and mechanism of injury.
Postoperative complications were reported. The Taras measurement outcome score was used to grade results as excellent, good, fair, or poor. (Table 2 ) (20) The Taras scale attempts to account for outcomes in which either S2PD or M2PD is greater than 8 mm but is not a "Good" result. Taras et al stated that because digital width is finite, 2-point discrimination greater than 8 mm could not be determined accurately without entering the nerve distribution of the contralateral digital nerve and reported 2-point discrimination greater than 8 mm with a score of ">8". Moving-and static 2-point discrimination do not always recover synchronously to the same level; thus, the lesser of a nerve's 2 measurements was chosen to assign it to its appropriate group in the final statistical analysis.
Results
Seventeen patients with 21 digital nerve lacerations underwent digital nerve allograft reconstruction. Three patients did not complete the study's 12-month minimum follow-up No postoperative complications such as infection or graft rejection occurred. One patient underwent an additional surgery for a 2-stage tendon reconstruction after failed primary tendon repair on the same digit as the nerve allograft, but the nerve allograft was not exposed during that procedure.
Debate exists about the best material and technique to repair digital nerve defects. One advantage of allografts compared to nerve conduits is the similarity between allografts and autografts in terms of 3-dimensional macro-and microstructure. Whitlock et al (16) compared Avance® processed allografts to type 1 collagen conduits and isografts (autograft) in a rat model. They demonstrated that processed allografts were superior to conduits for short (14 mm) 13 and long (28 mm) nerve gaps. Nerve conduit provides a hollow macrostructure and allows for collection of fibrin within the inner chamber to serve as the scaffold for axonal regeneration towards the distal stump. It lacks the internal microstructure and extracellular matrix of native nerve tissue. Whitlock et al (16) suggested that the basal laminal internal structure retained by advances in allograft processing enhances its nerve regeneration potential. A subsequent study quantified the nerve fiber density between allograft, nerve conduits, and isograft. Nerve conduits exhibited a consistent decrease in midgraft density compared to allografts and isografts for both short and long graft models. In addition, the nerve fibers were distributed in an unorganized pattern for conduits, whereas allografts and isografts demonstrated evenly distributed nerve fiber regeneration. (13) One limitation of the current study is the small sample size. An unblinded, hand therapist collected all outcome data, thus, it is impossible to quantify the impact of observer bias on the results. Future investigation with prospective randomized studies to compare allografts to nerve conduits would further delineate the value of these techniques. In addition, the performance of nerve allografts to bridge motor nerve gaps longer than 20 mm would further delineate the indications for this type of graft.
Pricing for processed Avance® nerve allograft is comparable to hollow-tube collagen conduits and is less than the costs associated with autograft harvest (including additional operating room time, physician time, and anesthesia time). At one of the hospitals where this series' nerve reconstructions were performed, Avance® nerve graft cost approximately $1550 for all lengths, and the estimated cost of similar lengths of collagen conduit ranged from $1,385 to $1470. The added expense that autograft harvest adds to a procedure can easily exceed the cost of off-the-shelf processed nerve allograft or hollow-tube conduit. Estimated OR cost per minute varies greatly from hospital to hospital, but published costs of operating room time (27) ranges from $65 -$166 per minute exclusive of physician and anesthesia fees. 
